TACBAC 07 - Sponsors and Exhibitors

• European Molecular Biology Laboratory -
  The European Bioinformatics Institute (EBI) is part of the European Molecular Biology Laboratory (EMBL) and is located on the Wellcome Trust Genome Campus in Hinxton, near Cambridge (UK). The EBI grew out of EMBL’s pioneering work in providing public biological databases to the research community. It hosts some of the world’s most important collections of biological data, including DNA sequences (EMBL-Bank), protein sequences (UniProt), animal genomes (Ensembl), three-dimensional structures (PDBe), data from microarray experiments (ArrayExpress), protein–protein interactions (IntAct), pathway information (Reactome) and the biomedical literature (CiteXplore). The EBI hosts several research groups and its scientists continually develop new tools for the biocomputing community.
  
  
• Nature Publishing Group -
  Nature Publishing Group (NPG) is the scientific publishing arm of Macmillan Publishers Ltd, combining the excellence of Nature, Nature research journals, Nature Reviews, Nature Clinical Practice journals and NPG academic journals to provide the world’s premier information resource for the basic biological and physical sciences. NPG is a global company, with headquarters in London and offices in New York, San Francisco, Washington DC, Boston, Tokyo, Paris, Munich and Basingstoke.
  
  
• BIOBASE GmbH -
  Based in Wolfenbüttel (Germany), with branch offices in Beverly, MA (USA) and Bangalore (India), BIOBASE GmbH is a leading provider of expertly curated biological databases for the life science industry. BIOBASE’s product portfolio, referred as the BIOBASE Knowledge Library (BKL), includes industry standards such as TRANSFAC®, TRANSPATH®, YPD™ and HumanPSD™ databases. In combination with BIOBASE’s powerful systems biology tool ExPlain™, the BKL can be used to analyse complex regulatory networks and identify key molecules linked to human disease.
  
  
• Chemical Computing -
  Chemical Computing Group is the producer and supplier of MOE (Molecular Operating Environment), the leading software system for drug discovery and protein modelling. MOE contains applications that cover the whole spectrum of drug discovery, from bioinformatics through structure-based drug design to cheminformatics, and is based on a unique language (SVL – Scientific Vector Language), which enables support of all hardware platforms, complete scientific customization, ease of deployment and integration, and a uniquely high level of customer support.
  
  
• Ingenuity Systems -
  Ingenuity Systems enable researchers to model, analyse and understand complex biological systems foundational to human health and disease. The Ingenuity products include pathways analysis software and knowledge bases for biologists and bioinformaticians, and enterprise knowledge management infrastructure, content and services for leading pharmaceutical and biotech companies. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, and Japan.
  
  
• Cresset -
  Cresset BioMolecular Discovery has developed a revolutionary way of describing molecules in silico. Our unique approach describes the surface properties (skin) of the molecules. It provides a ‘protein’s eye view’ of the ligand, allowing structurally diverse compounds with similar biological activity to be identified and enabling: rapid initiation of new drug discovery programs (no requirements for HTS); identification of novel, diverse, active compounds (hits or leads), from minimal starting information; and finding patent-free areas of chemistry for existing drugs.
  
  
• Linguamatics -
  Linguamatics’ I2E software provides a unique combination of search and text mining capabilities, helping organizations to maximize knowledge discovery from information resources. I2E is a versatile interactive information extraction system that lets you discover information that it would be impossible or intractable to find using conventional methods. The software’s powerful NLP capabilities mine large collections of documents, extracting relevant facts and relationships from unstructured and semi-structured content such as scientific papers, project reports, news feeds and patent documents. We work with many of the global top 20 Pharmaceutical companies, and applications span the R&D pipeline (including target ID and validation, biomarkers, safety/tox and pharmacovigilance) and commercial intelligence.
  
  
• Neonomy Ltd -
  Neonomy supplies hardware and software solutions for high performance and grid computing. Featured technology includes eXludus cluster optimization software, which eliminates performance bottlenecks inherent to traditional data handling. This allows efficient data delivery through Life Sciences clusters, significantly decreasing the time to results (e.g. Over 2.3 x BLAST performance enhancement vs parallel filesystems). Also featured will be the Tyan Typhoon 256 GFlop, 40 core Personal Supercomputer housed in a deskside cabinet, powered from a 13 A socket and requiring no air conditioning. Other technologies available include OpeniT license management and resource monitoring software and DC-powered clusters (up to 30% power savings).
  
  
• The Wellcome Trust -
  The Wellcome Trust’s mission is to foster and promote research with the aim of improving human and animal health. To achieve its mission, the Wellcome Trust supports research in universities and other academic centres in the UK and in overseas locations. We also manage our own projects and initiatives. We invest more than £400 million a year in biomedical research. Most of this goes to support research that adds to our understanding of health and disease but has no immediate application. Medical benefits may emerge years later. Several major successes have been achieved through Wellcome Trust funding, including sequencing of the human genome, development of the antimalarial drug artemisinin, pioneering cognitive behavioural therapies for psychological disorders, establishing the UK Biobank and building of the Wellcome Wing at the Science Museum.
  
  

Contact Information